Steve Seedhouse's Stock Ratings

Cantor Fitzgerald Analyst

Steve Seedhouse is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025

Updated: Dec 15, 2025

Overall Average Return

13.8%

Smart Score

66%

Overall Average Return Percentile

66th

Number of Ratings

12
Buy NowGet Alert
12/09/2025WVEBuy Now
WAVE Life Sciences
$16.88101.42%$12 → $34MaintainsOverweightGet Alert
11/24/2025BLTEBuy Now
Belite Bio
$141.099.15% → $154Assumes → OverweightGet Alert
11/13/2025KRROBuy Now
Korro Bio
$8.17DowngradeOverweight → NeutralGet Alert
11/06/2025XNCRBuy Now
Xencor
$16.60153.01%$40 → $42MaintainsOverweightGet Alert
11/06/2025INVABuy Now
Innoviva
$20.7049.76%$29 → $31MaintainsOverweightGet Alert
10/31/2025ETNBBuy Now
89bio
SuspendsOverweight → OverweightGet Alert
10/06/2025XNCRBuy Now
Xencor
$16.60140.96% → $40Assumes → OverweightGet Alert
10/02/2025CAMPBuy Now
Camp4 Therapeutics
$6.684.79% → $7Initiates → OverweightGet Alert
08/01/2025APLSBuy Now
Apellis Pharmaceuticals
$24.4863.4%$39 → $40MaintainsOverweightGet Alert
07/11/2025INVABuy Now
Innoviva
$20.7025.6% → $26Initiates → OverweightGet Alert
07/11/2025TVRDBuy Now
Tvardi Therapeutics
$4.231129.31% → $52Initiates → OverweightGet Alert
07/11/2025HROWBuy Now
Harrow
$47.1261.28% → $76Initiates → OverweightGet Alert
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free